Home / Archive by category "Περιοδικα"

Περιοδικα

HJA | VOLUME 9 | ISSUE 3 | JULY – SEPTEMBER 2018

Vol 9, No 3 (2018) Hellenic Journal οf Atherosclerosis Table of Contents Original Articles Height as marker of cardiometabolic risk; a combined analysis of two cohorts Konstantinos Christou Gkouvas, Alexandra Foscolou, Demosthenes Panagiotakos PDF Recurrent events among Acute Coronary Syndrome patients: gender-specific analysis from Aegean-Islands study ...
Περισσότερα

HJA | VOLUME 9 | ISSUE 2 | APRIL – JUNE 2018

  Letter to the Editor PCSK9 administration ameliorates non alcoholic fatty disease in patients with heterozygous familial hyperlipidemia A. Dimakopoulou, G. Sfikas, V. Athyros Editorial The role of lipid-lowering treatment in the secondary prevention of ischemic stroke E. Konstantinidou, K. Tziomalos  Original Articles The effects of atorvastatin 30 mg compared wi...
Περισσότερα

HJA | VOLUME 9 | ISSUE 1 | JANUARY – MARCH 2018

Table of Contents Editorial Chios Mastic Gum, the natural “tears” with lipid-lowering and anti-atherosclerotic properties: A new drug candidate? Aspasia Tzani, Ilias P Doulamis, Panagiotis Konstantopoulos, Dimitrios Tzivras, Despina N Perrea PDF Original Articles The long term effect of dietary habits and physical activity on type 2 diabetes incidence: 10-year f...
Περισσότερα

HJA | VOLUME 8 | ISSUE 4 | OCTOBER – DECEMBER 2017

    Editorial Low-density lipoprotein cholesterol targets: Lowest is best. M. Papagianni, A. Papagiannis, K. Tziomalos Original Article Attenuation of high-fat diet induced metabolic syndrome in rodents treated with Crocus sativus. P. Konstantopoulos, A. Tzani, I. P. Doulamis, A. Minia, A. Antoranz, A. M. Daskalopoulou, G. Marinos, L.Alexopoulos, D. N. Perrea ...
Περισσότερα

HJA | VOLUME 8 | ISSUE 3 | JULY – SEPTEMBER 2017

Reviews The role of angiopoietin-like 3 in the metabolism of lipoproteins: Therapeutic perspectives. C. V. Rizos, M. Florentin, M. S. Elisaf Nonalcoholic fatty liver disease and increased arterial stiffness: An established relationship with unclear pathogenetic mechanisms. C. Boutari, K. Tziomalos, A. Binas, A. Katsimardou, M. Doumas, V. Athyros, A. Karagiannis Atherosclerosis...
Περισσότερα

HJA | VOLUME 8 | ISSUE 2 | APRIL – JUNE 2017

  Reviews Clinical pharmacology of sodium glucose cotransporter 2 inhibitors V. Tsimihodimos, T. Panagiotopoulou, E. Tzavella, M. Elisaf The cardioprotective effects of polyphenols: a focus on classic cardiovascular risk factors E. Kokkou, n. Bozini, M. Lavda, K. Mourouzis, G. Siasos Diastolic dysfunction in end-stage renal disease patients E. Tzatzaki, M. Spartalis, ...
Περισσότερα

HJA | VOLUME 8 | ISSUE 1 | JANUARY – MARCH 2017

    Reviews Atherosclerosis as a risk factor for dementia and Alzheimer’s disease V. Zacharopoulou, G. Zacharopoulou , K. Karkoulias, E. Tsampalas A. Lazakidou Original Article The influence of diabetes on atherosclerosis and amyloid fibril formation of coronary arteries. A FT-IR spectroscopic study. Ch. Kotoulas, I. Mamarelis, E. Koutoulakis, M. Kyriakidou4,...
Περισσότερα

HJA | VOLUME 8 | SUPPLEMENT 1 | 2017

  Ένας κλινικός οδηγός από τον Ελληνικό Οργανισμό Εγκεφαλικών και το Ινστιτούτο Μελέτης και Εκπαίδευσης στη Θρόμβωση και την Αντιθρομβωτική Αγωγή. Συστάσεις για την αντιθρομβωτική αγωγή σε ασθενείς με ισχαιμικό εγκεφαλικό επεισόδιο. Γ. Ντάιος, Γ. Ανδρικόπουλος, Ε. Αρναούτογλου, Ε. Βαβουρανάκης, Γ. Γεροτζιάφας, Ε. Κορομπόκη, Μ. Ματσάγκας, Χ. Μηλιώνης, Β. Παπαβασιλείου, Α. Πλωμ...
Περισσότερα
Top